Captrust Financial Advisors Cytosorbents Corp Transaction History

Captrust Financial Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$1.76 - $3.22 $2,597 - $4,752	1,476 Added 330.94%	1,922 $4,000
Q1 2022 May 16, 2022	SELL	$2.88 - $4.23 $103 - $152	-36 Reduced 7.47%	446 $1,000
Q4 2021 Feb 14, 2022	BUY	$4.05 - $8.11 $1,259 - $2,522	311 Added 181.87%	482 $2,000
Q1 2021 May 17, 2021	BUY	$8.23 - $11.48 $1,407 - $1,963	171 New	171 $1,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.